Measurement and treatment of dyspnoea

Respiratory Medicine

Volumn 95, Issue 7, 2001, Pages 539-547

  Ambrosino, N ^a   Scano, G ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; INDOMETACIN; OPIATE; OXITROPIUM BROMIDE; OXYGEN; THEOPHYLLINE;

AIRWAY RESISTANCE; BREATHING; BREATHING MUSCLE; DISEASE SEVERITY; DYSPNEA; EXERCISE; FUNCTIONAL DISEASE; HUMAN; INTERVIEW; LUNG RESECTION; MEASUREMENT; MUSCLE FUNCTION; NUTRITION; OXYGEN THERAPY; PERCEPTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; QUESTIONNAIRE; RATING SCALE; REVIEW; SCORING SYSTEM; SYMPTOM; TOPICAL ANESTHESIA;

EID: 0034947193     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1111     Document Type: Review

References (90)

1. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
2. Pulmonary rehabilitation. Joint ACCP/AACVPR evidence-based guidelines
3. Reductions in exercise lactic acidosis and ventilation as a results of exercise training in patients with obstructive lung disease
4. Dyspnoea. Mechanisms, assessment, and management: A consensus Statement
5. Pathophysiology of dyspnoea
6. Descriptors of breathlessness in cardiorespiratory diseases
7. Distinguishable types of dyspnoea in patients with shortness of breath
8. Dyspnoea
9. Breathlessness in patients with chronic airflow limitation
10. Neural mechanisms underlying the sensation of breathlessness: Kinesthetic parallels between respiratory and limb muscles
11. Perception of changes in airflow resistance in obstructive pulmonary disorders
12. Magnitude scaling of externally added loads to breathing
13. The significance of the respiratory symptoms and the diagnosis of chronic bronchitis in a work population
14. Measurement of pain
15. Measurement of feeling using visual analog scales
16. The measurements of dyspnoea contents, interobserver agreement, and physiologic correlates of two new clinical indexes
17. Clinical measurement of dyspnoea
18. Chronic exertional dyspnoea and respiratory muscle function in patients with chronic obstructive pulmonary disease
19. Validation of the UCSD shortness of breath questionnaire
20. Psychophysical bases of perceived exertion
21. Target dyspnoea ratings predict expected oxygen consumption as well as target heart rate values
22. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation
23. Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease
24. Breathlessness in patients with severe airflow limitation
25. A measure of quality of life for clinical trials in chronic lung disease
26. Changes in dyspnoea, health status, and lung function in chronic airway disease
27. Dyspnoea in the-Elderly
28. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction (CAO)
29. Analysis of clinical methods used to evaluate dyspnoea in patients with chronic obstructive pulmonary disease
30. A self-complete measure of health status for chronic airflow limitation
31. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise
32. Relationship between ventilation and breathlessness during exercise in chronic obstructive airway disease is not altered by prevention of hypoxemia
33. Methods to assess breathlessness in healthy subjects: A critical evaluation and application to analyse the acute effects of diazepam and promethazine on breathlessness induced by exercise or by exposure to dioxide
34. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation
35. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation
36. 2 in obstructed patients with mild hypoxemia
37. Correlations between dyspnea, diaphragm and sternomastoid recruitment during inspiratory resistance breathing in normal subjects
38. Respiratory sensation and pattern of respiratory muscle activation during diaphragm fatigue
39. Ventilatory drive at rest and perception of exertional dyspnoea in severe COPD
40. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD
41. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease
42. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airway disease
43. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease
44. Respiratory muscles and dyspnoea
45. Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease
46. Drug treatment of breathlessness: Contrasting effects of diazepam and promethazine in pink puffers
47. Effect of alprazolam on exercise and dyspnoea in patients with chronic obstructive pulmonary disease
48. Diazepam in the treatment of dyspnoea in the 'pink puffer' syndrome
49. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety
50. Effects of small particle aerosols of local anaesthetic on dyspnoea in patients with respiratory disease
51. Ventilation and breathlessness on maximal exercise in patients with interstitial lung disease after local anesthetic aerosol inhalation
52. Experimental results of vagal blockade in cardiopulmonary disease
53. Pulmonary denervation effects on dyspnoea and ventilatory pattern during exercise
54. Effect of Vagotomy on the breathing pattern and exercise ability in emphysematous patients
55. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnoea
56. The effect of indomethacin on breathlessness in patients with diffuse parenchymal disease of the lung
57. Prostaglandin E2 inhalation increases the sensation of dyspnea during exercise
58. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation
59. Qualitative aspects of exertional breathlessness in chronic airflow limitation pathophysiologic mechanisms
60. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease
61. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructed pulmonary disease
62. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease
63. Dose response relation to oral theophylline in severe chronic obstructive airways disease
64. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease
65. Effect of theophylline on diaphragm strength and fatigue in patients with chronic obstructive pulmonary disease
66. Strategies in the treatment of dyspnoea: Disease specific
67. The respiratory muscles
68. Respiratory muscle strength and maximal voluntary ventilation in undernourished patients
69. Diaphragm and body weight in emphysema
70. Effect of chronic airflow limitation on sternomastoid muscle thickness
71. The effect of supplemental oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease
72. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease
73. Nutritional assessment of patients with chronic obstructive pulmonary disease and acute respiratory failure
74. Nitrogen and energy relationships in malnourished patients with emphysema
75. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients
76. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease
77. Functional changes during nutritional repletion in patients with lung disease
78. Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma
79. Impaired perception of dyspnoea in patients with severe asthma
80. Assessment and follow up of patients prescribed long term oxygen therapy
81. Exercise training in COPD patients: The basic questions
82. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease
83. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease
84. Respiratory muscle training in chronic airflow limitation: A meta-analysis
85. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia
86. Exercise and noninvasive ventilatory support
87. Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physicial training in severe chronic obstructive pulmonary disease
88. Lung-volume reduction improves dyspnoea, dynamic hyperinflation and respiratory muscle function
89. Lung volume reduction surgery does not improve diaphragmatic contractile properties or atrophy in hamsters with elastase-induced emphysema